Healthcare Professional Portal

Return to portal
PI & AE

Viv is struggling with chronic insomnia

Not an actual patient

Living with the consequences of insomnia for months or years

Has tried many things to improve her sleep:

  • Non-prescription remedies
  • Relaxation techniques
  • Better sleep hygiene
  • Previously trialled prescription medication, though not treated currently
How could QUVIVIQ™ make a difference for your patients’ night-time sleep?

Finding it hard to keep up with her daily responsibilities

See how QUVIVIQ™ could help improve your patients’ daytime functioning

What underlying mechanism could be keeping Viv up at night?

Learn more

Adverse events must be reported. Healthcare professionals are asked to report any suspected adverse reactions via www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in Google play or Apple App store. Adverse events should also be reported to ds.safety.uk@idorsia.com.

This site is intended only for healthcare professionals resident in the United Kingdom.

UK-DA-00123 I Date of preparation: June 2023
Copyright © 2023 Idorsia Pharmaceuticals Ltd

Sign in

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

At night, patients with chronic insomnia may be a state of hyperarousal1

In chronic insomnia, research suggests that wake-promoting regions of the brain may be overactive both night and day (hyperarousal).1,2

 

Orexin is a neurotransmitter that promotes wakefulness and provides a specific target for intervention.3

QUVIVIQ™ works differently to sedating hypnotics by blocking the action of orexin, reducing wake-drive and allowing restorative sleep to occur without altering the proportion of sleep stages3‑5

  1. Morin CM, et al. Nat Rev Dis Primers. 2015; 1: 15026.
  2. Nofzinger E, et al. Am J Psychiatry. 2004; 161: 2126–2129.
  3. Roch C, et al. Psychopharmacology. 2021; 238(10): 2693–2708.
  4. QUVIVIQ™ Idorsia Pharmaceuticals LTD, summary of product characteristics.Last updated: March 2023.
  5. Chaput JP, et al. Nat Sci Sleep. 2018; 10: 421–430.
Find out more
Find out more
Welcome back!

Please complete the form below to sign in.

You don’t have an account? 

Sign up

You are now leaving pro.idorsia.uk

You are now leaving pro.idorsia.uk. You will now be redirected to an independent third-party site that is maintained outside of this website.
You are now leaving pro.idorsia.uk. The linked website provides helpful information if you are having trouble sleeping. It is neither owned or controlled by Idorsia Pharmaceuticals Ltd. Idorsia accepts no responsibility for the content or services of the linked site.
Cancel
Go to link

UK-DA-00445 | Date of preparation: May 2024

Copyright ©2025 Idorsia Pharmaceuticals Ltd
Confirming your contact information and preferences means that you agree that we, Idorsia, manage your personal data in our Client Relationship Management system to document, customise, plan, and conduct our interactions with you and, to analyse and segment your interactions, interests, preferences, and scientific activities in order to interact with you in a way we think is most relevant to you. It also means that you agree that we will send you Idorsia standard or personalised medical, company or product related information and material via email based on your choices and on what we think is of interest to you. You further consent that we process your personal data for this. For more information about us, our processing of your personal data and your rights, please see our Privacy Notice.
Create an account
Access our in-depth e-learning resources on chronic insomnia
Title *
First name *
Last name *
Professional email *
Password *
Specialty *
Professional registration number *

Select below to keep informed of further resources:

You already have an account? 

Sign in

Gain access to resources on Chronic Insomnia​

Register to get access to:

  • Insightful videos
  • Patient resources
  • E-Learning programme
  • And details about us and our offerings